Biovail unit settles with DoJ for $24.6 mln over Cardizem

marketwatch.com     May 16, 2008            

SAN FRANCISCO (MarketWatch) -- Biovail Pharmaceuticals, a subsidiary of Biovail Corp. , will pay $24.6 million as part of a settlement with the U.S. Department of Justice related to activities surrounding the 2003 commercial launch of Cardizem, the pharmaceutical company said Friday. Biovail... [read full story]                

Full Coverage

Biovail unit settles with DoJ for $24.6 mln over Cardizem (at MarketWatch)

yahoo.com     May 16, 2008          

SAN FRANCISCO (MarketWatch) -- Biovail Pharmaceuticals, a subsidiary of Biovail Corp. , will pay $24.6 million as part of a settlement with the U.S. Department of Justice related to activities surrounding the 2003 commercial launch of Cardizem, the pharmaceutical company said Friday. Biovail...                

comments

Stocks in focus for Monday

menafn.com     May 17, 2008          

Devon Energy, Biovail, E-Trade NEW YORK (Menafn - MarketWatch) -- Among the companies whose shares are expected to see active trade in Monday's session are Devon Energy Corp., Biovail Corp. and E-Trade Financial Corp. Devon Energy Corp.'s DVN received an upgrade from Fitch Ratings on its issuer...                

comments